Summary
Previous studies have shown that triiodothyronine (T,) enhances the effect of dexamethasone on phosphatidylcholine (PC) synthesis in organ cultures of fetal rat lung. The aim of this study was to investigate whether similar interactions occurred in vivo and to explore possible mechanisms for this phenomenon.
Injection of 7.0 mg/kg T, into pregnant rats on d 18 and 19 of gestation resulted in a mean fetal serum T3 level of 2380 ng/dl on d 20 (control, 8 4 ng/dl) and in maximal (34%) stimulation of choline incorporation into PC. Injection of 1.0 mg/kg betamethasone using the same protocol a s for T3 resulted in maximal stimulation of 33% and administration of both hormones together produced a 69% increase, an additive affect. The percentage of P C that was disaturated was increased with betamethasone, but decreased with T3. Betamethasone treatment resulted in an increase in the whole lung disaturated P C content, but treatment with T3 did not. Betamethasone administration also increased fetal serum T3 levels, but T3 injection did not produce elevated fetal serum corticosterone levels.
Injection of T3 in vivo, or exposure of explants of 18-d fetal lung to 100 nm T3 for up to 48 h did not result in an increase in cytoplasmic glucocorticoid binding or nuclear translocation of the receptor steroid complex. Exposure of explants to glucocorticoid or T3 in vivo or in culture (dexamethasone, 100 n M and Th 100 nM, for 48 h) resulted in a significant increase in the activity of cholinephosphate cytidylyltransferase, an enzyme in the choline incorporation pathway of PC synthesis. Exposure of explants to the combination of hormones resulted in stimulation that was equal to the sum of that produced by the single hormones but was not statistically significantly different from the glucocorticoid effect. The activities of other enzymes of phospholipid synthesis were not increased by exposure to either hormone, in vivo or in vitro.
The additive effects of T, and glucocorticoid with regard to choline incorporation into P C in fetal rat lung suggest that combined hormone therapy may be useful for the prevention of respiratory distress syndrome in humans. Further animal studies are required, however, before clinical use can be considered. Abbreviations CDP, cytidine 5' diphospho DIMIT, 3,s-dimethyl-3'-isopropyl-~thyronine PC, phosphatidylcholine RDS, respiratory distress syndrome
T3, triiodothyronine
Interactions between glucocorticoids and thyroid hormones occur in a number o f tissues (31) . A 
MATERIALS AND METHODS
In vivo studies. In order to avoid problems associated with direct fetal injection, all hormones were injected into the mother.
Timed pregnant Sprague Dawley rats (Charles River Breeding Laboratories, Cambridge, MA) were injected once in the morning on d 18 and 19 of gestation with either saline, betamethasone, T3 in 0.9% saline, or a combination of the above hormones. The rats were killed by decapitation on d 20 and the fetuses removed under sterile conditions. One-half of the fetuses was used for enzyme assays and the other half was weighed, decapitated, and bled. The serum was retained for analysis of hormone levels. The lungs were then removed, dissected free of non-pulmonary tissue and large airways, and chopped into 1-mm3 cubes by means of a mechanical tissue chopper. The lung pieces from fetuses from the same litter were pooled and used for measurement of the rate of choline incorporation into PC and disaturated PC, as described previously for lung explants (9) , and determination of phospholipid content or glucocorticoid binding.
Organ cultilres. All experiments were performed with explants of 18-d fetal rat lung cultured in serum-free chemically defined medium for 48 h. The organ culture technique has been described previously (9, 10) . Briefly, 1-mm3 explants of fetal lung were placed on either side of a 60-mm tissue culture dish, containing 2 ml of Waymouth's MB 75211 medium with 100 U penicillin and 100 pg streptomycin per ml. The dishes were then rocked from side to side on a rocking platform so that at any one time, half of the explants was exposed to the culture medium and the other half to the atmosphere of 95% 02-5% CO*. The explants were exposed to culture medium alone (controls) or medium containing either 100 nM dexamethasone, 100 nM T3, or a combination of these two agents for 48 h. These concentrations were shown to be optimal in a previous study (1 1). At the end of the culture period, explants were harvested for analysis of enzyme activity, glucocorticoid binding, or incorporation of choline into PC and disaturated PC as described previously (9) .
Tissue anal-vsis. Phospholipids were extracted in chloroform and methanol and then quantitated by the method of Dodge and Phillips (6) . Protein was measured by the method of Lowry et al. (20) and DNA by the mithramycin binding technique of Hill and Whatley (14) , using bovine serum albumin and calf thymus DNA as standards, respectively.
Glz~cocorticoid binding. Intact cell binding was determined in 1-mm3 cubes derived from either the in vivo or in vitro experiments by methods described previously (2, 12) . Briefly, the tissue blocks were exposed to 35 nM [3H]dexamethasone in the presence or absence of a 100-fold excess of unlabeled dexamethasone, for 3 h at 37°C. The binding assay reached equilibrium under these conditions. At the end of this incubation, the explants were washed with ice cold saline, homogenized, and separated into a nuclear and cytoplasmic fraction by centrifugation. The nuclear fraction was washed twice to remove unbound dexamethasone, and radioactivity in the nuclear pellet was counted in a scintillation spectrometer. The cytoplasmic fraction was filtered through a column of Sephadex G-25 to separate the bound from the free dexamethasone. The radioactivity in the bound fraction (the eluate) was then determined.
Hortnonal lcvels. Serum total corticosterone concentration was determined by a modification of the competitive protein binding radioassay of Murphy (24) . T3 was determined by a double antibody radioimmunoassay (T, kit, Nichols Institute, San Pedro, CA).
Enzvrne a.s.suy.r.. Fetal lungs were rapidly removed, cleared of nonpulmonary tissue. and homogenates (20%, w/v) were prepared with a Potter-Elvehjem tissue grinder in 0.33 M sucrose/ 10 mM Tris HCI/I mM EDTA (pH 7.4). The supernatant fraction was prepared by centrifugation at 105,000 g for 1 h. Cholinephosphate cytidylyltransferase was assayed in the supernate and all other enzymes in the homogenate. All assays were optimized with respect to time, protein concentration, pH, and substrate concentrations.
Choline kinase (EC 2.7.1.32) was assayed by measuring the rate of [methyl-14C]choline incorporation into choline phosphate as described previously (22) . Cholinephosphate cytidylyltransferase (EC 2.7.7.15) was assayed by measuring the rate of incorporation of radioactivity from [methyl-14C]choline phosphate into CDPcholine as described previously for the rabbit (29) except that the concentration of choline phosphate was 2 mM and that of cytidine triphosphocholine was 8 mM. This enzyme was assayed both with and without the addition of 1.1 mM phosphatidylglycerol to the reaction mixture (29) . Cholinephosphotransferase (EC 2.7.8.2) was assayed by measuring the rate of incorporation of radioactivity from CDP [methyl-14C]choline into PC in the presence of 1,2-dioleoylglycerol or I ,2-dipalmitoylglycerol. The assay with dioleoylglycerol was the same as that described previously (28) . except that the concentration of CDPcholine was 0.3 mM. The assay in the presence of dipalmitoylglycerol was the same, except that the diacylglycerol was prepared by sonication at 65°C in the presence of phosphatidylglycerol and Polysorbate 20 as described by Miller and Weinhold (23) . When the diacylglycerols were prepared by the latter procedure, cholinephosphotransferase activities were similar in the presence of dioleoylglycerol and dipalmitoylglycerol but, in contrast to the data of Miller and Weinhold (23), were not greater than in the presence of dioleoylglycerol as prepared conventionally (28) .
Phosphatidate phosphatase (EC 3.1.3.4) was assayed by measuring the rate of release of inorganic phosphate from phosphatidic acid (3) . and lysolecithin acyltransferase (EC 2.3.1.23) by measuring the rate of incorporation of radioactivity from [I-14C] palmitoylCoA into PC as described previously (9) except that the concentration of palmitoylCoA was 70 pM and PC was separated by thin layer chromatography in chloroform:methanol:concentrated NH40H: water (50:35:4:2, by volume).
Phosphatidate cytidylyltransf'erase (EC 2.7.7.41) was assayed by measuring the rate of incorporation of [5-3H]CTP into CDPdiacylglycerol and CDPdiacylglycerolinositol-3-phosphatidyltransferase (EC 2.7.8.11) by measuring the rate of incorporation of my0-[2-~I-I]inositol into phosphatidylinositol as described previously (1 7). The activities of glycerophosphate phosphatidyltransferase (EC 2.7.8.5) and phosphatidylglycerophosphatase (EC 3.1.3.27) combined were assayed by measuring the rate of incorporation of ~-[U-~~C]glycer01-3-pho~phate into phosphatidylglycerol as described previously (26) except that 0.4 mM CDPdiacylglycerol from egg PC was used and the pH was 7.4.
Chemical~s. Radiochemicals were purchased from New England Nuclear (Boston, MA), CDPdiacylglycerol from Serdary (London, Ontario, Canada) and all other biochemicals from Sigma (St. Louis. MO). Betamethasone (Celestone Soluspan suspension) was obtained from Schering Corporation (Kenilworth, NJ) and dexamethasone and T3 from Sigma. Culture medium was purchased from Grand Island Biological Co. (Grand Island, NY).
Stati.sticu1 una~v.sis. In the in vivo studies, separate animals were used for each treatment group, whereas in the in vitro studies a common pool of explants was prepared from a number of litters and the various treatment groups were then derived from this common pool of tissue. Paired analysis was therefore performed on the in virro material. In all experiments the T3 and glucocorticoid groups were compared to the control group by two-way analysis of variance. The combined treatment group was evaluated by two-way analysis of variance (for statistical interactions) and by a single r test for difference from the glucocorticoid group. RESULTS Dose-response relationships for T3 and betamethasone were established before in vivo studies of the effects of combinations of these agents on fetal lung phospholipid synthesis. The effects of varying maternal T3 injections on fetal serum T3 levels are shown in Table 1 . A small increase occurred with 0.7 mg/kg and a marked increase with 7 mg/kg. An earlier study using the rabbit had shown that high doses of DIMIT, a thyroid hormone analog which crosses the placenta, produced an increase in cortisol levels in the fetuses (1). For this reason fetal serum corticosterone levels were measured in the rat fetuses. It is apparent that even high doses of T3 did not produce a rise in total corticosterone levels. The rate of choline incorporation into PC was increased by all the doses of Ti that were used; because a plateau was reached by 7 mg/kg this dose was used in further studies. A dose-response study with betarnethasone was also carried out using doses of 0.2. 0.5. 1.0, and 5.0 mg/kg. Betamethasone was injected into the doe once daily on d 18 and 19 and the rate of choline incorporation into PC was determined in the fetal lungs on d 20. Dose-dependent stimulation was noted with increasing doses up to 1 mg/kg, but there was no further increase above that. One milligram per kilogram of betamethasone was, therefore, used in all further studies.
The effects of injecting T3, betamethasone, or a combination of these hormones are shown in Table 2 . Injection of T3 into the mother produced a significant 28-fold increase in fetal serum T3 levels. Injection of betamethasone resulted in a 2-fold increase in serum T3 levels and the combination of hormones produced levels which were far in excess of those produced by T, alone. Fetal serum corticosterone levels were not increased by T j injec- tion and the level of this steroid was below the lower limits of the assay in those animals that had been treated with betametlnasone, reflecting suppression of endogenous corticosterone production. Treatment with Ti produced a significant, 34% increase in the rate of choline corporation into PC and betarnethasone treatment resulted in a 33% increase. which was also significant. Cornbination treatment resulted in a 69% increase. This effect was significantly greater than that produced by betarnethasone alone. When incorporation into disaturated PC was studied. the eflect of T3 was decreased whereas that of betamethasone was enhanced. The effect of combined treatment was again approximately equal to the sum of the individual effects of these hormones, but was not significantly different from that of betarnethasone alone. This is due to the fact that whereas betamethasone produces an increase in the percentage of PC that is disaturated. T3 does not. In fact Ti produced a significant decrease in this percentage. This finding is consistent with previous in vivo data from this laboratory ( 1 1).
When fetal lung PC accumulation was examined (Table 3 ) it was found that betamethasone produced an increase in the disaturated PC content whereas T3 did not. Betamethasone treatment again resulted in an increase in the disaturated PC:PC ratio, whereas T, treatment did not. This finding is also consistent with in vifro observations. Exposure of explants of 18-d fetal rat lung to 100 nM dexarnethasone for 48 h resulted in a 2-fold increase in the disaturated PC content but there was no increase after exposure to 100 n M T,. These concentrations had been shown previously to produce maximal stimulation of the rate of choline incorporation into PC (1 1). Similarly, the percentage of PC that was disaturated was increased by dexmethasone, but not by Ti (data not shown, n = 3).
In an attempt to explore possible mechanisms for the enhancement of glucocorticoid action by T,, the effect of T, on specific cytoplasmic and nuclear binding of dexamethasone was examined in vivo and in vitro ( Table 4 ). In the in vivo studies 7'3 (7 mg/kg) was administered for 48 h. T j treatment did not result in any change in cytoplasmic or nuclear binding of dexamethasone. 4 Statistically significant difference from control value by two-way analysis of variance: P < 0.05. 11 P < 0.005.
:: Statistically significant difference from betamethasone value. The combined hormone group was compared only with the betamethasone group by 1 test: l ' < 0.05. 
Control
T i Betamethasone Explants of 18-d fetal rat lung were also exposed to 100 n M T 3 for 6, 24, or 48 h. Cytoplasmic and nuclear binding of dexamethasone were examined after each of these periods. The only significant finding was that after 48 h there was a small decrease in cytoplasmic binding. The activities of a number of enzymes of phospholipid synthesis were also measured in the lungs of fetuses that had been treated in vivo ( Table 5 ). The only significant finding was that both betamethasone and T3 significantly increased the activity of cholinephosphate cytidylyltransferase when this enzyme was assayed in the absence of phosphatidylglycerol. Treatment with T resulted in a 43% increase in activity and with betamethasone, a 96% increase. Combined hormone treatment produced a 166% increase. Although the effect of the combined hormones was equal to the arithmetic sum of the effects of the individual hormones, it was not statistically significantly different from the effect of betamethasone alone. Addition of phosphatidylglycerol to the assay mixture resulted in a marked increase in the activity of the enzyme in all experimental groups and abolished the effect of hormone treatment.
Similar data were obtained in the in vitro experiments. The activities of all the enzymes listed in Table 5 were examined after exposure of explants of 18-d lung to dexamethasone (100 nM), T3 (100 nM), or a combination of the two hormones for 48 h. As is shown in Table 6 , when cholinephosphate cytidylyltransferase was assayed without phosphatidylglycerol there was a 56% increase after exposure to Ti, a 99% increase after exposure to dexamethasone, and a 158% increase after exposure to both hormones. Although the combined hormone effect was again equal to the arithmetic sum of the effects of the two hormones, it was also not significantly different from the dexamethasone effect. The activity of none of the other enzymes examined was significantly increased by exposure to either hormone in vitro. There was no significant difference in protein:DNA ratio after injection of any of the hormones alone or in combination. opmental follow-up studies of infants treated antenatally with glucocorticoids (2 l), concern regarding the use of these hormones * Experimental conditions and statistical analysis are described in Table 2 ** Enzyme activity expressed as nmol. min-' . mg protein-'. t Assayed without phosphatidylglycerol in the reaction mixture.
$Assayed with phosphatidylglycerol in the reaction mixrure. $ Assayed with dioleoylglycerol as substrate.
11 Assayed with dipalmitoylglycerol as substrate.
ll Statistically significant difference from control value P < 0.05. # P < 0.01.
administration in the prevention of RDS, we had shown previously that there were additive interactions between T3 and dexamethasone with regard to some parameters of PC synthesis in organ cultures of fetal rat lung (1 1). In order to examine this role in vivo, we felt that it was desirable to develop a model in which the effect of T, on the fetus could be examined after maternal (as opposed to fetal) injection. In most species thyroid hormones do not cross the placenta to any great extent and for this reason studies of thyroid effects on fetal lung maturation had usually involved direct fetal injection, usually of thyroxine (T4). Fetal injection, even of saline, is a stress which in and of itself results in accelerated lung maturdtion (27) , thereby complicating the interpretation of the findings. Knobil and Josimovich (1 8) showed that there was significant transplacental passage of T, and T4 in the rat. As our data in this study indicate, it is possible to obtain a serum level of T, that produces maximal stimulation of choline incorporation into PC with a maternal injection of 7 mg.kg-'.d-'. The resulting mean fetal serum level (24 h after the last injection) of 2380 ng/dl is equivalent to a concentration of 37 nM. Even if a !arge amount of the hormone is bound, this concentration is still well above the level at which the dose-response curve for T j stimulation of choline incorporation into PC plateaued in our organ culture studies ( 1 l), which is consistent with the finding that higher doses of T3 produced no further stimulation of choline incorporation. It is also of interest that, unlike DIMIT administration to the pregnant rabbit (I), T3 injection did not produce elevated fetal levels of circulating glucocorticoid.
Betamethasone treatment resulted in a significant increase in fetal T3 levels. It is known that glucocorticoids promote the conversion of fetal T4 and T3, rather than reverse T j (19) and this could account for the increase in T j levels. The tremendous increase in T, levels produced by combined hormone administration could only have come about by increased passage of hormone across the placenta. Analysis of variance indicated that betamethasone and T, had synergistic effects with regard to fetal Ti levels.
Both betamethasone and T3 significantly increased the rate of choline incorporation into PC. In the case of the combined hormone treatment the effect was equal to the sum of the individual hormone actions, an additive effect. The combined effect was significantly different from the betamethasone effect when a single t test was applied to these two results. T, did not, however, produce an increase in DSPC content, whereas betamethasone did. The reason for this is not clear. Ballard ct al. (I), using DlMIT in the fetal rabbit, had shown that there was a marked increase in lung lavage PC content. Because we were measuring whole lung disaturated PC content (a good lavage procedure cannot be performed in the fetal rat), it is possible that our measurements were not sensitive enough to detect an increase in surfactant-related disaturated PC. An alternative explanation is that T, treatment may result in increased disaturated PC turnover. with no accumulation of this phospholipid in the lung tissues.
The betamethasone effect on choline incorporation could not be accounted for by the increase in T, levels because the two hormones produce different effects in vivo and in vitro (10) . Similarly the combined hormone effect could not be accounted for by the large increase in Tj levels as the dose-response data indicated that administration of 7 mg.kg-'.d-l of T, alone resulted in the maximal T j effect.
Our findings are. in general, consistent with those of Hitchcock (15) who found that metopirone treatment or adrenalectomy decreased the effect of T4 (injected directly into rat fetuses) on the morphologic maturation of the lung. Dow and Torday (7) have also indicated in a preliminary report that whereas direct injection of T4 into fetal rabbits produced no greater stimulation of choline incorporation into disaturated PC than did saline, T, injection did enhance the effect of directly injected dexamethasone.
The enhancement of glucocorticoid action by T, could not be accounted for by any change in cytoplasmic or nuclear binding of the steroid. This finding is similar to that reported in pituitary cells in which there are interactions between T, and glucocorticoid with regard to growth hormone synthesis (3 I). In that system T3 did not produce any change in glucocorticoid binding or vice versa. The work of Smith and Sabry (33) suggests that T, increases the sensitivity of the type I1 cell to fibroblast pneumonocyte factor, which is believed to be released by mesenchyrnal cells in response to glucocorticoid stimulation.
Fetal lung cholinephosphate cytidylyltransferase activity has previously been reported to be stimulated by glucocorticoids and estrogen in a number of species, both in vivo and in vitro (3, 5, 10, 17, 29, 30) . To our knowledge this is the first report of stimulation of this enzyme by T,. Fetal lung choline-phosphate cytidylyltransferase activity is increased by inclusion of acidic phospholipidsin the reaction mixture (8, 16) . In this and previous studies (16, 17) the stirnulatory effects of the hormones were not observed when the enzyme was assayed in the presence of phosphatidyiglycerol. This suggests that the hormones produce their effects by activating the enzyme rather than by increasing its amount. There is accumulating evidence from nonpulmonary systems that cholinephosphate cytidylyltransferase catalyzes the rate-limiting step in PC biosynthesis (32, (34) (35) (36) (37) and in a recent study, Post et ul. (25) showed that is also the rate-limiting step in PC synthesis in type I1 cells isolated from adult rat lung. It remains, however, to be established if these hormonal effects on enzyme activity are of physiologic significance. Although only cholinephosphate cytidylyltransferase was stimulated by glucocorticoids in this study, other enzymes of lung phospholipid synthesis (particularly phosphatidate phosphatase in the rabbit) have also been reported to be stimulated by these steroid:; in other studies (30) .
The data reported here, therefore, suggest that there is an additive interaction between T, and betamethasone with regard to choline incorporation into PC. This supports the view that combined hormone administration may be more effective than single hormones in preventing RDS in humans. More information is, however, clearly required before clinical use of combined hormone therapy can be considered.
